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!~18--~-6~ Particular Benefit of Platelet GPllb/llla Blockade 
. . . . .  and Full Heparln In Patients With Peripheral 
Vascular Disease Undergoing PTCA 
J ,M  MIII0r, N, Goalmy, C Balog, A.M Lmcofl. E J  Topoi Duke Umve~s~ty 
M~tC,~tI C~..nter, Ctel,.elar~ Clinic Foun~=~hon. USA 
AthetO~lototic vascular (llsoase may clintcally manifest as coronary, c~re. 
bral, or I~nphoral disease, but all fmms appear to benefit from antiplafetet 
therapy We hypothesized that pIS with peephefal vascular d~sease (PVD) 
who were undergoing coronary angroplasty as parl el the EPILOG Iris! wouM 
h~ n greater treatment 0ffecl from at~iximab (ciTE31 than thc~c w/o PVD 
PIs wtth PVD (n =~ 305) were older, heavier, more omen female, with hyperion. 
SlO0: (~abete~ and pnor PTCA Among PVD ptS, those randomized to ¢~3-  
standard do~e hepann (n = t06i had a lower event rate when compare0 
with placebo . hel~lnn |199% VS 306%, p = 00,5) than C7E3 * tow ~e 
hel~nn (29(P~,, p ~ 0 66) In non~PVD pts (n = 2446) the combmec! eno'po~nt 
el death, MI, r~asculanzal~on at 6 months was 2~ 5% for pts receiving c7E3 
• hep~nn ~t~ 25% in pla4:ebo • hepann (p = 0 08) There was no in~reaso ~n 
n~or  bteed~og or stroke in PVD pls 
[ Kaptan,M¢~f t-ai!ur~ [:~timilt¢~ 
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Cot~ctu~n The presence of PVD apl~ars to I~ a marker of ~mpro.~ed 
bewef;,t from c7E3 + standard do~e hepann treatment dunng coronary inter- 
vention 
• Balloon Angioplasty Versus Oebulkin 9 for 
Treatment  o f  D i f fuse  In-stent Reslenosls 
HL. Daueffnan. DS Balm. AM Sparano, C.M. Gibson, RE  Kuntz. 
J.P Carrozza Jr. DJ. Cohen. Beth Israel Deaconess Medical Center. 
Boston. Mass. USA 
Background Balloon ar~oplasty (BAt for drttuse (n-stent restet-,os~s ~s::rts 
=n h~Jh rates el target vessel re~eulanzat~on tTVR) possibly retate~3 to 
rt..--s~,~ua| plaque burden. By reducing this ptaqu~ burden, c~13ulP~=r,.g m~ght 
Improve C{m,,~al Outcomes 
Meffmds We compared BA aJone (n = 30) or debut',~ncj by rotahonal In 
= 26~ Or directional in = 4) atherectomy . BAm 60 coc~ec~h~e patients 
undergoing treatment of ~ttuse ~n steel restenesls 
ResultS: Basehne charactenstics were similar lay quan~atwe coronary 
an~jrapby.  Procedural s~',cess was I00%, wtth no comphcatlon~ and 
no increase m non-Q wave MI dlssed[on of "no-fellow" tn the debulkmg 
group Debulkmg * BA resulted in sig~itlcantiy lower best-procedure residual 
stenoses and improved flow rates SLX month follow- up was available for 
all patients and showed a strong trend towards less TVR ~,~,'h c~b~tkmg 
Independent pred=doP3 el repeat TVR were a smaller hnal mm~mum luminal 
diameter (p = 0 007) and longer les~on length iP = 00(36) 
PTCA Oel3uiktr~l • PTCA P value 
Les~nten~thlmml It 8 : 8 1 94 : 46 NS 
Rete=e~,ce ~e~el mrr,) 2 8 : 0 6 2 O : O 6 NS 
Stenos=sprel%) 809 ~ 132 78 7 : 114 NS 
Stenostsposll%l 25 : 13 18 : 10 eel 
Flnalhamoc(Junl 114 : 2S ~]{} : 24 oeet 
One year TVR 46% 28% 0 t8 
Concluston~: 1 ) For treatment of d~ffuse in stent restenosts, debuIking 
BA is safe and leads to a lower residual stenoscs than BA alone. 2 ) Since a 
larger final MLD predicts less TVR. a debulking strategy may be the treatment 
ot choice for diffuse in stent restenosis 
• Mechanisms and Results of Additional Stent 
implantation to Treat Focal In-stent Restenosis 
R. Mehran. A.S Abizaid. G.S. Mintz, A. Abizaid, AJ. Lansky. K.M, Kent, 
L.F. Satlet. AD. Picha~. TA. Bucher, J J. Popma, M.B. Leon. Washington 
Hospital Center. Washington, DC, USA 
Focal restenosis within Palmaz-Schatz stents is usually treated with repeat 
PTCA; using intravascular ultrasound (IVUS), the increase in lumen area 
has been shown to be a combination o1 tissue extrusion and additional stent 
expansion with significant residual neointimal tissue. In an attempt o further 
reduce the need for subsequent target lesion revasculadzation, 56 focal 
restenotic stented lesions (21 vein graft, 35 native vessel) in 51 pts were 
treated with additional Plamaz.Schatz stem =mpl~m~bon Pattern~ of tO(~l 
re-sleet restono~,ls wore Identltlod angtograph~call t ~nd (:onhfn-~l wdh IVUS 
27 at one of the margins, 19 at the c:ontral arbcutahon and 10 w0hm the body 
Angtogtaphic Ioston t0ngth measure0 6 9 = 1 8 mm IVUS rnea~uremems 
Ot sleet lumeL and mhmat hyperplasla (IH) aroa~ pfe* aed Post,addltlonal 
slenl Implanlabon wore used t0 assess, mo~h.~ni~m5 ot tu~ ef~laf~j~rr~nl 
. . . . . . .  p 
Mlnlmt~m iumen ,~e~ Im, mPi t f) z O 7 7 5 ~ p 2' 0 (~:~J !
IH ~ea I~am 21 5, 7 ~ I h 0 ? ~ 0 3 I:~ 0(1{ I
~. IH area P~E~,~SUr.-----------------O~ 50 ~ t 7 mm ~ (or 85 ~ 11% 0l -~ lumen area), 
¢onvemety, b, stent area measutc-d only 09  -, 0 4 ram: Residual IH are~ wa~ 
9 : 2% ot final lumen area. F,nat anglog~ph¢ d*ameter stenos=s measured 
10 ~ 12% Target les,on revascu!arlzat~on at I yr was 27%. 
We Conct~e In line treatment el fOcatin.slent restenos~s, add0~onal stem 
tmplanlatlon increased lumen area pemanly by neomtimal tissue e~l[u~on 
with ~urprmmgly little add~tlor,al steer expansion Although hnal ~arr~ett~ 
steno~=~ t10%) and re~=dual neomt~mal tissue (9%) were tow, TLR at t yr 
wa~ 27% 
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11•9-59 j  My~ard ia l  Infarct ion A f te r  Rotat iona l  
J~therectomy: Pred)ctonJ and Influence on Late 
Outcome in the STRATAS Tria l  
J W Moses. PL. Whitlow, R.E Kuntz, B L Sllaraf, M Chauhanr 
B Pmo-Mauch DE Cuthp Lenox Hd! Hosprta!, New York, NY BJth Israel 
Deaconess A~tcal  Center. Boston. MA, USA 
Elevat~n ot CK-MB occurs frequently after rotational atherectomy (ROTe) 
STRATAS was a 500 patient rand~rntzed comparison of two ROTe ~rate- 
g(es CPK. CK-MB (CKMBR - ratio of normal) and ECGs were prosl:~-'llvely 
collected and a~tud=eated by a bhndea core laboratory into 3 MI care ~ones 
Type I. CKMBR . 1 and 3: Type 2, CKMBR , 1 and - 3 wrth ST abt ~rnal- 
itios o~ CKMBR :3 and 8; or. T~,}e 3, Q wave MI or CKMBR ,8 levee 
patients W~l emergent CAE]G or .,eaYh w~th~n 24 hours of the prt. edure 
were e~ctt.ld'~3 from analys.s ;,, ,3 ,,~ :lhvanate model el CK elevatlG,, only 
the presence of no retto~ !:_~-:~r~ ~brupt ctO=-ure, s=deDranch ~klg=l~tll 
larger final MLD an~l moderate to heavy cak:mm were ~l-.3epende.t pre- 
dtctors More aggressive ROTe. age gender, ~rabetas and HTN were net 
predlclors Nine , '~onlh follow-up iS available tot 85'~ of the patlenls There 
W~ r,o assoc,atl~Jn ot MI and late dea~'l (p = 0 3,4) or a composite of la~e 
aeath, recurrent MI or repeat revascutarlzat)en (p = 064)  
Em~p~mr NO M; Any MI Type t Type 2 Type 3 
n ~,~ 330 ~ 71i 134 leg) 65 (141 4319) 2fi 16) 
~lea~ 7 !2 1 ) 513 7) :314 61 2 i4 6l 0 l0 O) 
CGmp,~5:!~ r17!35 5! ~,3 !~ %l ~S ~3,R 5) It., (3491 13 (~e] 
Conctuszon. MI occurs frequently after ROTe and ~s predicted by anqlo 
graphic comply:sirens, vessel calclficatTon and a larger hnal MLD There Js 
no assoctatron Ot MI and late mortahty or TVF 
[ 1 1 89-60  t The Impact of ReoPro or Lower Speeds on 
Platelet Aggregation During Rotational 
Atherectomy 
M. Reisman. S Speck. J L Petersen. R J Westcott. R Fel. V Harms, 
S. Bogoslan. O Oillard, B Shuman Swedzsh Medlc.tl Center and BSC 
Northwest Technology Center. Se~rRle. WA. USA 
Rotational atherec?omy is associated with an nncreased incidence of slow 
flow and creahne kmase elevatton which ~s reduced by ReePro, tmpffcatmg 
platelet activation as a potential mechanism. This study tests the effects 
el burr speed or ReoPro on piatetet aggregation asmg an =n vwtre model. 
A 2.0 mm Rotablator" burr was rotated in 2.5 mm inner diameter silicone 
tubing. Hepannized human blood was pumped through the tubing at 10 
cc/min, and subjected to ablation speeds o! 180,000 rpm, 140,000 rpm and 
0 (control). ReoPro (5 /,glml) was mixed wire blood for 5 min. and the 
test at 180,000 rpm was repeated. The blood was collected and analyzed 
immediately lor the quantity and size of platelet aggregates using an optical 
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microscopy technique, The mioroscoplst wee blinded to the rotational speed 
of the samples, The numbers of aggregates 20-60 l~ m dlameter/ml blood are 
shown below as n functlen of Ihe retnllonsl speed with or without ReoPre '~'. 
Number of Plstolet Rotational Speed 
Aggrsgm= lOOk rpm lOOk rpm + RooPro 140k rpm Control (0 ram) 
20-00 I,m dis. 
meter/ml blood' 4131 ~ 3330 934 ¢ 715 420 ~ 435 240 ;t ;293 
R#n.go_ 444-13809 t 33-2011 t 11-17;2;2 03-1 ;222 
' n ,~ R0; ~ I;1(t Day,; p - 0,00;2 for ~11 comparisons, 
NOt ell blOOd samples responded ta RooPro, In 4/20 samples, RooPro 
d~raesaa tea number el plutetet aggregates oeused by the relating burr by 
loss then 20%, Plstolet aggregates In all nsmples subjected to lower speed 
worn decreased by grouter than 75%, (Rstlo of # of aggregates', 140k/160 + 
RooPro 0,89), 
Conclusion: This in vitro tasting suggests that Ihe use of the Roteblotor 
system et 140,000 rpm (ItS minimum approved speed) may be more eflootlve 
In reducing pletolot aggregation than ReoPro, Whether mduoad epeed will 
provide clinical benefit in mduelng slow flow and post prooedure omaline 
kisses elevation Is being investigated, 
~ Rotational Inemeaes Circulating Atheroctomy 
Platalet-Monoayte Complexes 
M,G, Tmuth, S,1, Simon, Z,,X, ,~' C,'=, ', ~mtlh, J, Mlckelson, N,S, Ktetman, 
F)~ College of Med¢tne, HOl~fon, TX, USA 
Rotational Athere~tomy (RA) feollllates the debutklng of various lesion types 
but Is asseslated with an i~resse In NQMI, Proposed mechanisms include 
plugging by debris and ptetalat (pit) actlvetlon, Using whole blood flow cytom. 
airy we competed several ma~ers of pit activation in peripheral blood', [pit. 
monocyte complexes, plt.neufrophll (PMN) complexes, P.selecttn (C062), 
and activated GP lib.life expression (PAC,1)] In patients undergoing RA with 
those undergoing coronary angloplazty (PTCA), peripheral angloplssty (PA), 
or coronary anglography (CA), No consistent increase attar the procedure 
could be detected fat ptt.PMN, CD,62, er PAC-t, However, plt.monocyls 
complexes Increased following RA', 
RA PA nTC^ CA 
Pm 140 .t ;2 13,0 ~ 1,5 5 7 i. O 12.4 ± ;2 
1 Hr Post 3~,2' -t 64 165 ~, 2 23 9 t a 3 193 ± 5.9 
24 Hr Post 15,2 ~ 26 98 .t 4,8 8!~ ~ 5.3 143 i 34 
'p • O.0Svs Pm 
Pg/monoc~la complexes represent a stable measure of pit ecttvetton in 
peripheral blood while direct assessment ol peripheral pit activation are less 
conclusive, Measurement of plVmonocyte complexes uggests that RA acti- 
vales pit more than PA, PTCA or CA. increased pit activation may represent 
a mechanism for the higher incidence of NQMI following RA, 
• Intrecoronary Adenosine Administered During 
Rotational Athoroctomy of Complex Lesions In 
Native Coronary Arterl le Reduce the Incidence of 
'no Reflow' Phenomenon 
G,P, Hanna, P, Yhlp, K, FuJlse, G,W, Schrelh, O,R, Resales, H,V. Anderson, 
R,W, Smaltlng, The University ol Texas Medical School and Hermann 
Hospital, HooMon, Texas, USA 
Background: Rotational athorectomy (RA) of complex, highly calcified lesions 
has been associated with a high incidence of 'no roflow' ranging from 6-15% 
and concomllant myocardial necrosis with adverse prognostic implications, 
There are no uniform strategies for preventing this complication, The role ol 
tntracoronary adenosine for the pmvenlion of this phenomenon during RA 
has net been tully evaluated. 
Methods: We studied the procedural outcome of 122 patients who un- 
derwent RA of complex native coronary artery lesions. Fifty two patients 
received no adenosine, but a veriely of other agents. Seventy patients re- 
ceived intracoronary adr, nosine boluses (24 mcg to 48 mcg prior to and after 
each RA run), There was no difference m the type of lesion studied, run time, 
or Burr to artery ratio (0.6--0.7) between the two groups. 
Results: Six patients without adenosine xpedenced 'no reflow' (11,6%) 
with resultant infarclion in the target artery territory, while only one of seventy 
patients (1,4%, p = 0,023) in the adenosine group experienced no rellow, No 
untoward complications were observed during adenosine ',nf~sion, 
Conclusion: Intracoronary adenosine bolus administered uring rotational 
atheractomy is easy, safe and may significantly reduce the incidence of 'no 
roflow' which may improve the 30 day outcome of this procedure. 
• Coronary After Rotational Atherectomy Slanting 
Vemus Coronary Stentlng Alone: 
An Anglogrephle Compsr l lon  
X. Wang, I. Mesas, A, Colombo, J, Moses. Centre Colomt~ Hospital, Milan 
Ilaly, Lanox Hill Hospital, New York NY, USA 
Purpose: To retrospeotlvoly compare the immediate and slx month anglo- 
graphic englographlo utcome for these two different approaches, 
Methods; A total of 178 pellents (270 lesions) who had stoats Implanted 
in de novo, non o~ludod vessels and had six month nnglogmpht¢ fogow 
up were classified Into two groups: steal alone (146 patients, 226 lesions) 
and rotostent (32 patients, 44 lesions), Acute and follow.up (FU) roeultl am 
shown In the table: 
Rate,tent Slant p vslue 
Lenten l~pe tB2+C) 9?,68% 66,0?% ~OCOt 
C~l¢ium 04.00% e.93% ~ O 001 
Pm mtemnc~ tram) ;2.9~  0~45 3 0 * 0.51 
Lesion length tram) 1;~,27 * 7.3r 11 Tt * 0.54 ns 
Post MLO (ram) 3.05 * O 56 3.0 t 054 ns 
Pos|%D~ 365 t 1037 e.10 :t t0.4;~ P4L 
FU MLO tram) I '/~ ~ 08~ 1 91 * 0.'19 ns 
FU %OEI 40 80 ~r ~;~ 380~ ~ 21 29 mi 
ACute (}sin (mm) ~}.1 ~ 0.59 1 ,e8 1 Q 53 ns 
Lslalass (ram) 1.33 ~ 071 1,1 ~i 0,)'2 ms 
LOSS ind~zt 0,ST * 037 O 50 ~: 0.44 ns 
Restenosts 40 91% 31.4~'% ns 
Conc/us/on: Despite the presence of morn uMaverabte ang~gre~ char- 
aetedst~(,'s in the lesions treated wflh mtablatton and stealing, the immediate 
and long.term angtographlc results were similar to those lesmns treated w~b 
stenttng alone, 
~ T h o  Ro l l  of Adjunctive Bal loon Oilltatlon in 
Directional Coronary Athemctemy Without 
Sublntimal Resection 
H, "Parent, 1", Suzuki, O, Kate, 1". Fulita, K. Ueno, S. Takase, K. Fulii, 
T, Aizawa, H, Kurogana, M. Kijima, H. Ode. Shags Me(P..al Center tot Adult 
D~seases, Moayama, Japan 
ABACAS (_Adjunctive I~elloon Angloplasty Following Coronary Athemctomy 
Study) is a prospective randomized multicenter teat to study whethm ag- 
gressive debulking with IVUS.guided DCA followed by adjunctive balloon 
dilatation reduces rastenosls. Restonosis rates were 23.6% for adjunctive 
balloon and 19,6% for DCA alone (n,s,). To elucidate the influence ol deep 
wall resection and adjunctive balloon on the restenosis rates, histological 
and angiographic study were peflormed in the same cohod. Accordlo 9 to the 
presence of subintimal resection and adjunchve balloon, eligible 194 pts were 
divided into four subgroups, DCA wtlh lotimal resection (D/I) group consisted 
ot 38 pts, DCA with subintimal resection (D/S) group ,57 pts, DCAroalloon 
with intlmal resection (D/liB) group 48 pts and DCAlbelloon with subintimal 
resection (D/S/B) group 53 pts. 
Results: QCA analysis revealed more (n.s.) late toss (D/I: 0.7 ± 0.5, D/S: 
0.9 ± 0.6, D/t/B: 1.2 + 0.7, D/S/B: 1,0 + 0.6 ram) and higher (n.s.) loss index 
(D/I: 49%, D/S: 59%, D///B: 64%, D/s/e: 50%) in D/I/B group than the other 
groups. Restenosis rate of D/I/B group was significantly higher than the other 
groups (D/l: 13.9%, D/S: 17.6%, D/Z~: 34.8%, D/S/S: 12,0%)(p < 0.05). 
Conclusion: Adjunctive balloon following DCA without subintimal resec- 
tion increased rastenosis rata. IVUS-guided complete removal of atheroma 
without adjunctive balloon may be the best strategy on DCA. 
1•0---- 1 Considerations in Use of Heparin, 
Adenosine,  K+ Channe l  Opener, and 
GPIla/ll lb Inhibit ion Dur ing Interventional 
Procedures 
Wednesday,  April 1, 1998, Noon-2 :00  p.m. 
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• Prolonged Heparin Uncomplicated Coronary After 
Interventions: A Prospective Randomized Trial 
A. Garachemani. M. Fleisch, U. Kaufmann, B, Meier, Cardiology, University 
Hospital, Inselspital, Bern, Switzerland 
The aim of this trial was to evaluate if hepafin infusion after uncomplicated 
coronary interventions reduced the incidence of acute cardiac complications. 
